KCG
IMGN

Knight Capital Group’s Immunogen Inc IMGN Stock Holding History

Knight Capital Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$267K Buy
+16,109
New +$261K ﹤0.01% 2385

Other funds holding IMGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Knight Capital Group's IMGN Position: Q2 2013 in Review

Knight Capital Group opened a new position in Immunogen Inc (IMGN) in Q2 2013: 16,109 shares worth $267K. The stake represents ﹤0.01% of the portfolio and ranks #2385 among its holdings.

128 funds tracked by Wall St. Rank hold IMGN as of Q2 2013.

  • Knight Capital Group held 16,109 shares of Immunogen Inc worth $267K as of Q2 2013.
  • Immunogen Inc was a new Knight Capital Group position in Q2 2013.
  • Immunogen Inc made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #2385 holding.
  • 128 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.